ALLO Operating Cash Flow Growth
Allogene Therapeutics Inc · Operating Cash Flow Growth
ALLO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported40.85%period ending
ALLO TTM Cash from Operations YoY % (-368.51% → 40.85%)
Year-over-year change
High-resolution chart · PNG
ALLO operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 40.8492% | |
| 44.646% | |
| 25.4888% | |
| 27.1337% | |
| 24.4627% | |
| 13.0678% | |
| 15.7458% | |
| 11.7068% | |
| 3.9971% | |
| -3.6872% | |
| -7.8061% | |
| -20.7315% | |
| -16.1716% | |
| -7.4612% | |
| -19.3207% | |
| -36.4966% | |
| -48.5445% | |
| -64.8068% | |
| -60.5762% | |
| 3.8833% | |
| 7.7946% | |
| 16.4236% | |
| 16.2046% | |
| -43.1276% | |
| -59.6988% | |
| -97.4304% | |
| -207.5941% | |
| -368.5137% |